Glibenclamide-pregnenolone derivative has greater hypoglycemic effects and biodistribution than glibenclamide-OH in alloxan-rats
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
22660215
DOI
10.5507/bp.2012.028
Knihovny.cz E-zdroje
- MeSH
- alloxan MeSH
- experimentální diabetes mellitus krev MeSH
- fixní kombinace léků MeSH
- glibenklamid analogy a deriváty farmakokinetika terapeutické užití MeSH
- hypoglykemika metabolismus farmakokinetika MeSH
- krevní glukóza metabolismus MeSH
- krysa rodu Rattus MeSH
- metformin terapeutické užití MeSH
- potkani Wistar MeSH
- pregnenolon farmakokinetika terapeutické užití MeSH
- tkáňová distribuce MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- alloxan MeSH
- fixní kombinace léků MeSH
- glibenklamid MeSH
- hypoglykemika MeSH
- krevní glukóza MeSH
- metformin MeSH
- pregnenolon MeSH
AIM: The present study was designed to investigate the activity of two glibenclamide derivatives on glucose concentration. An additional aim was to identify the biodistribution of glibenclamide derivatives in different organs in a diabetic animal model. METHODS: The effects of two glibenclamide derivatives on glucose concentration were evaluated in a diabetic animal model. In addition, glibenclamide derivatives were bound to Tc-99m using radioimmunoassay methods. To evaluate the pharmacokinetics of the glibenclamide derivatives over time (15, 30, 45 and 60 min) the Tc-99m-glibenclamide conjugates were used. RESULTS: The results showed that glibenclamide-pregnenolone had greater hypoglycemic activity than glibenclamide or glibenclamide-OH. The data also showed that the biodistribution of Tc-99m-glibenclamide-OH in all organs was less than that of the Tc-99m-glibenclamide-pregnenolone derivative. CONCLUSIONS: The glibenclamide-pregnenolone derivative had greater hypoglycemic effects and its biodistribution was wider than glibenclamide-OH. The data suggest that the steroid nucleus may be important to the hypoglycemic activity of the glibenclamide-pregnenolone derivative and this could be related to the degree of lipophilicity induced by the steroid nucleus in the chemical structure of glibenclamide-pregnenolone.
Citace poskytuje Crossref.org